Sex-specific effects of brain LC-PUFA composition on locomotor activity in rats

Salem, 2001, Mechanisms of action of docosahexaenoic acid in the nervous system, Lipids, 36, 945, 10.1007/s11745-001-0805-6 Uauy, 2001, Essential fatty acids in visual and brain development, Lipids, 36, 885, 10.1007/s11745-001-0798-1 Sinclair, 1975, Long chain polyunsaturated fatty acids in the mammalian brain, Proc Nutr Soc, 34, 287, 10.1079/PNS19750051 Fleith, 2005, Dietary PUFA for preterm and term infants: review of clinical studies, Crit Rev Food Sci Nutr, 45, 205, 10.1080/10408690590956378 McCann, 2005, Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals, Am J Clin Nutr, 82, 281, 10.1093/ajcn/82.2.281 Carlson, 1999, Polyunsaturated fatty acid status and neurodevelopment: a summary and critical analysis of the literature, Lipids, 34, 171, 10.1007/s11745-999-0351-2 Wainwright, 2002, Dietary essential fatty acids and brain function: a developmental perspective on mechanisms, Proc Nutr Soc, 61, 61, 10.1079/PNS2001130 Enslen, 1991, Effect of low intake of n-3 fatty acids during development on brain phospholipid fatty acid composition and exploratory behavior in rats, Lipids, 26, 203, 10.1007/BF02543972 Levant, 2004, Decreased brain docosahexaenoic acid during development alters dopamine-related behaviors in adult rats that are differentially affected by dietary remediation, Behav Brain Res, 152, 49 Moriguchi, 2000, Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration, J Neurochem, 75, 2563, 10.1046/j.1471-4159.2000.0752563.x Sheaff-Greiner, 1999, Rats with low levels of brain docosahexaenoic acid show impaired performance in olfactory-based and spatial learning tasks, Lipids, 34, 239, 10.1007/BF02562305 Takeuchi, 2002, Influence of a dietary n-3 fatty acid deficiency on the cerebral catecholamine contents, EEG and learning ability in rat, Behav Brain Res, 131, 193, 10.1016/S0166-4328(01)00392-8 Filipek, 1997, Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls, Neurology, 48, 589, 10.1212/WNL.48.3.589 Cummings, 1993, Frontal-subcortical circuits and human behavior, Arch Neurol, 50, 873, 10.1001/archneur.1993.00540080076020 Davis, 1991, Dopamine in schizophrenia: a review and reconceptualization, Am J Psychiatry, 148, 1474, 10.1176/ajp.148.11.1474 Weinberger, 1988, Schizophrenia and the frontal lobe, Trends Neurosci, 11, 367, 10.1016/0166-2236(88)90060-4 Byne, 1999, The neurochemistry of schizophrenia, 236 Meltzer, 1976, The dopamine hypothesis of schizophrenia: a review, Schizophr Bull, 2, 19, 10.1093/schbul/2.1.19 Chalon, 2001, Polyunsaturated fatty acids and cerebral function: focus on monoaminergic neurotransmission, Lipids, 36, 937, 10.1007/s11745-001-0804-7 Fenton, 1999, Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia, Biol Psychiatry, 47, 8, 10.1016/S0006-3223(99)00092-X Freeman, 2000, Omega-3 fatty acids in psychiatry: a review, Ann Clin Psychiatry, 12, 159, 10.3109/10401230009147106 Richardson, 2000, The potential role of fatty acids in attention-deficit/hyperactivity disorder, Prostaglandins Leukot Essent Fatty Acids, 63, 79, 10.1054/plef.2000.0196 National Research Council, 1996 Reeves, 1993, AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet, J Nutr, 123, 1939, 10.1093/jn/123.11.1939 Dodge, 1967, Composition of phospholipids and of phospholipid fatty acids and aldehydes in human red cells, J Lipid Res, 8, 667, 10.1016/S0022-2275(20)38890-8 Folch, 1957, A simple method for the isolation and purification of total lipids from animal tissues, J Biol Chem, 226, 497, 10.1016/S0021-9258(18)64849-5 Zail, 1979, Fatty acid composition of erythrocytes in hereditary spherocytosis, Br J Haematol, 42, 339, 10.1111/j.1365-2141.1979.tb01148.x Morrison, 1964, Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron trifluoride-methanol, J Lipid Res, 5, 600, 10.1016/S0022-2275(20)40190-7 Carrie, 2000, Specific phospholipid fatty acid composition of brain regions in mice. Effects of n-3 polyunsaturated fatty acid deficiency and phospholipid supplementation, J Lipid Res, 41, 465, 10.1016/S0022-2275(20)34485-0 Favreliere, 1998, Chronic dietary n-3 polyunsaturated fatty acids deficiency affects the fatty acid composition of plasmenylethanolamine and phosphatidylethanolamine differently in rat frontal cortex, striatum, and cerebellum, Lipids, 33, 401, 10.1007/s11745-998-0221-y Moriguchi, 2004, Effects of an n-3-deficient diet on brain, retina, and liver fatty acyl composition in artificially reared rats, J Lipid Res, 45, 1437, 10.1194/jlr.M400087-JLR200 Galli, 1971, Effects of dietary fatty acids on the fatty acid composition of brain ethanolamine phosphoglyceride: reciprocal replacement of n-6 and n-3 polyunsaturated fatty acids, Biochim Biophys Acta, 248, 449, 10.1016/0005-2760(71)90233-5 Moriguchi, 2001, Reversal of docosahexaenoic acid deficiency in the rat brain, retina, liver, and serum, J Lipid Res, 42, 419, 10.1016/S0022-2275(20)31666-7 Sagvolden, 1998, Attention deficit/hyperactivity disorder — from brain dysfunctions to behaviour, Behav Brain Res, 94, 1 Sleator, 1981, Can the physician diagnose hyperactivity in the office?, Pediatrics, 67, 13, 10.1542/peds.67.1.13 Carpenter, 1998, Schizophrenia, 27 File, 1997, Animal models of anxiety, 8.3.1 Heiderstadt, 2000, The effect of chronic food and water restriction on open-field behaviour and serum corticosterone levels in rats, Lab Anim, 34, 20, 10.1258/002367700780578028 Overton, 2004, Behavioral and physiologic responses to caloric restriction in mice, Physiol Behav, 81, 749, 10.1016/j.physbeh.2004.04.025 Jones, 1990, Sex differences in voluntary locomotor activity of food-restricted and ad libitum-fed rats. Implications for the maintenance of a body weight set-point, Comp Biochem Physiol A, 96, 287, 10.1016/0300-9629(90)90694-N Hall, 1984, The role of body size in climbing and locomotor behavior of protein-malnourished and well-nourished rats, Dev Psychobiol, 17, 91, 10.1002/dev.420170109 Faracone, 1999, The neurobiology of attention deficit hyperactivity disorder, 788 Martin, 1980, Exploratory behaviour of rats at oestrus, Anim Behav, 28, 900, 10.1016/S0003-3472(80)80151-5 Szatmari, 1982, The epidemiology of attention-deficit hyperactivity disorders, Child Adolesc Psychiatr Clin North Am, 1, 361, 10.1016/S1056-4993(18)30592-3 Delion, 1996, alpha-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex, J Neurochem, 66, 1582, 10.1046/j.1471-4159.1996.66041582.x Zimmer, 2000, Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex, Neurosci Lett, 284, 25, 10.1016/S0304-3940(00)00950-2 Zimmer, 1999, n-3 polyunsaturated fatty acid deficiency and dopamine metabolism in the rat frontal cortex, Lipids, 34, S2519, 10.1007/BF02562309 Zimmer, 1998, Chronic n-3 polyunsaturated fatty acid diet-deficiency acts on dopamine metabolism in the rat frontal cortex: a microdialysis study, Neurosci Lett, 240, 177, 10.1016/S0304-3940(97)00938-5 Zimmer, 2002, The dopamine mesocorticolimbic pathway is affected by deficiency in n-3 polyunsaturated fatty acids, Am J Clin Nutr, 75, 662, 10.1093/ajcn/75.4.662 Zimmer, 2000, Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids, J Lipid Res, 41, 32, 10.1016/S0022-2275(20)32071-X Kodas, 2002, Reversibility of n-3 fatty acid deficiency-induced changes in dopaminergic neurotransmission in rats: critical role of developmental stage, J Lipid Res, 43, 1209, 10.1194/jlr.M200132-JLR200 Emsley, 2003, Clinical potential of omega-3 fatty acids in the treatment of schizophrenia, CNS Drugs, 17, 1081, 10.2165/00023210-200317150-00003 Richardson, 2004, Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum, Prostaglandins Leukot Essent Fatty Acids, 70, 383, 10.1016/j.plefa.2003.12.020